Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma. (Q50534164)

14 March 2018

http://europepmc.org/abstract/MED/26201842

title

Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma. (English)

1 reference

14 March 2018

http://europepmc.org/abstract/MED/26201842

author

Kazuhiko Kurozumi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Yoshihiro Otani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Joji Ishida

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Tomotsugu Ichikawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Manabu Onishi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Kentaro Fujii

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Yosuke Shimazu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Tetsuo Oka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Toshihiko Shimizu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Isao Date

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

publication date

23 July 2015

1 reference

14 March 2018

http://europepmc.org/abstract/MED/26201842

published in

Brain Tumor Pathology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

245-252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

14 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Biologic parameters that correlate with the prognosis of human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Pathway inhibition: emerging molecular targets for treating glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Expression of cyr61, a growth factor-inducible immediate-early gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

The CCN family of proteins: structure-function relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Double-labelling immunohistochemistry for MGMT and a "cocktail" of non-tumourous elements is a reliable, quick and easy technique for inferring methylation status in glioblastomas and other primary brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Cyr61 suppresses growth of human endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Immunohistochemical evaluation of O6 -methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Expression and regulation of CCN genes in murine osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

An extent of resection threshold for newly diagnosed glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-015-0227-3

10.1007/S10014-015-0227-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201842%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference